Lupin incorporates unit in US to focus on oncology products

Drug maker Lupin on Tuesday said it has incorporated a wholly-owned subsidiary in the US.

migrator

Published:21st Apr, 2021 at 9:47 AM

New Delhi

The new unit, Lupin Oncology Inc (LOI), will be engaged in development/co-development and commercialisation of multiple oncology products globally, the Mumbai-based company said in a regulatory filing.

Lupin has a sizable presence in the US market, the world's biggest market for pharma products.

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android

Lupin incorporates unit in US to focus on oncology products

Drug maker Lupin on Tuesday said it has incorporated a wholly-owned subsidiary in the US.

Also Read

TN to regularise over 1,000 contract nurses in first phase; stir withdrawn

Let Periyar open eyes of DMK government: Anbumani on Vanniyar quota

Do not grant approval for expansions in Cuddalore SIPCOT: Ramadoss

Visa delays leave H-1B families stranded abroad amid tougher US vetting

ISRO deploys BlueBird-6 in record mission; Kulasekarapattinam launch complex set for 2027, says chairman